Updated Jul 16, 2026
BRAWLEY OTIS W has filed 2 SEC Form 4 filings across 2 companies in the last 90 days — buying. Lifetime open-market purchases: $20K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-10 | INCY | INCYTE CORP | A — Grant or award | 1.6K | $0.00 | |
| 2026-03-23 | A | AGILENT TECHNOLOGIES, INC. | A — Grant or award | 888 | $111.75 | $99K |
| 2026-03-23 | A | AGILENT TECHNOLOGIES, INC. | A — Grant or award | 2.2K | $111.75 | $241K |
| 2025-06-10 | INCY | INCYTE CORP | A — Grant or award | 2.5K | $0.00 | |
| 2025-03-31 | LYEL | Lyell Immunopharma, Inc. | P — Open-market purchase | 35.6K | $0.56 | $20K |
BRAWLEY OTIS W is a corporate insider — currently tracked as Insider of Lyell Immunopharma, Inc. (LYEL). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 1 open-market purchases ($20K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live BRAWLEY OTIS W profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.